수의료 치료 계획 시장 예측(-2034년) : 솔루션 유형, 도입 형태, 대상 동물, 치료 유형, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Veterinary Treatment Planning Market is accounted for $0.4 billion in 2026 and is expected to reach $1.2 billion by 2034 growing at a CAGR of 14.7% during the forecast period. Veterinary Treatment Planning refers to the systematic process of developing individualized medical care strategies for animals based on clinical evaluation, diagnostic findings, medical history, and therapeutic objectives. It involves selecting appropriate treatments, medications, surgical interventions, rehabilitation protocols, and follow-up care to address specific health conditions. By integrating evidence-based veterinary practices and patient-specific information, veterinary treatment planning supports accurate clinical decision-making, optimizes treatment outcomes, enhances patient recovery, and promotes effective long-term animal health management.

Market Dynamics:

Driver:

Specialty care complexity

The increasing complexity of veterinary specialty care is driving substantial demand for structured treatment planning solutions that guide practitioners through evidence-based therapeutic protocols. Oncology, neurology, and orthopedic cases require multi-modal treatment sequences involving surgery, chemotherapy, radiation, and rehabilitation that benefit from systematic planning tools. Veterinary referral hospitals require standardized care pathways that ensure consistent quality across rotating residents and specialists. End-user general practitioners increasingly encounter complex cases that exceed their training, creating demand for decision support tools. The integration of treatment planning into electronic medical records normalizes protocol-driven care.

Restraint:

Customization requirements

The highly individualized nature of veterinary treatment planning presents significant challenges for standardized software solutions. Each animal presents unique combinations of species, breed, age, weight, comorbidities, and owner constraints that resist templated protocol application. Veterinary professionals require extensive customization capabilities that increase software complexity and implementation costs. The diversity of veterinary species and conditions exceeds the scope of any single planning database. These customization demands necessitate flexible platform architectures and substantial configuration investments.

Opportunity:

Oncology protocol standardization

The expansion of veterinary oncology services presents transformative market expansion opportunities for treatment planning platforms. Cancer treatment protocols involving chemotherapy scheduling, radiation planning, and surgical margins require precise coordination that software systems facilitate. Standardized oncology protocols improve outcomes through consistent dosing, timing, and monitoring across treatment centers. Growing pet owner willingness to pursue cancer treatment for companion animals expands the addressable market. Partnerships between veterinary oncology specialists and software developers create evidence-based protocol libraries.

Threat:

Practitioner autonomy concerns

Veterinary professionals may perceive treatment planning software as undermining their clinical autonomy and professional judgment. Experienced practitioners with established therapeutic approaches may resist protocol-driven recommendations. Liability concerns when deviating from system-generated plans create legal uncertainty. The time required to input case data and review system recommendations may exceed the efficiency benefits for straightforward cases. These professional culture challenges necessitate positioning treatment planning as decision support rather than directive.

Covid-19 Impact:

The COVID-19 pandemic accelerated veterinary treatment planning adoption as remote consultations required structured documentation and clear care protocols. Telemedicine providers relied on treatment planning templates to ensure consistent virtual care quality. However, deferred elective procedures temporarily reduced surgical planning system utilization. Post-pandemic, the normalization of hybrid care models and continued specialty care growth support sustained investment in treatment planning infrastructure.

The Treatment Planning Software segment is expected to be the largest during the forecast period

The Treatment Planning Software segment is expected to account for the largest market share during the forecast period, due to its foundational role in structuring therapeutic decisions across all veterinary specialties. Treatment planning software provides templates, calculators, and decision trees that guide practitioners through diagnostic workup, therapeutic options, and monitoring schedules. The platforms integrate drug databases, dosing calculators, and interaction checkers that reduce medication errors. Growing regulatory requirements for veterinary prescription documentation drive the adoption of structured planning systems. Major veterinary software vendors embed treatment planning modules into comprehensive practice management platforms.

The AI-Based Treatment Recommendation Platforms segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-Based Treatment Recommendation Platforms segment is predicted to witness the highest growth rate, driven by advances in machine learning for pattern recognition across large veterinary outcome datasets. Artificial intelligence algorithms analyze similar cases, treatment responses, and complication rates to generate personalized recommendation rankings. The technology reduces diagnostic and therapeutic variability between practitioners and institutions. Cloud-based deployment makes advanced recommendation engines accessible to general practices without specialist consultation. Research partnerships between technology companies and veterinary teaching hospitals continuously expand training datasets and validate algorithm accuracy.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to advanced veterinary specialty infrastructure and early adoption of clinical decision support technologies. The United States leads with extensive networks of veterinary specialty hospitals and academic institutions that generate the clinical data required for evidence-based planning tools. Canada contributes through its progressive veterinary education and well-funded research programs. High pet owner willingness to invest in specialty care drives demand for sophisticated treatment planning. Major companies, including IDEXX Laboratories, Zoetis, and Mars Science & Diagnostics, maintain significant market presence across the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding veterinary specialty services and increasing professionalization of clinical practice. China and Japan represent major growth markets with growing investment in veterinary oncology, cardiology, and neurology specialties. Australia and South Korea demonstrate high technology adoption rates and advanced diagnostic capabilities. Growing awareness of evidence-based veterinary medicine supports the adoption of structured treatment planning. The region's expanding software development sector provides indigenous platform development capabilities.

Key players in the market

Some of the key players in Veterinary Treatment Planning Market include IDEXX Laboratories, Inc., Covetrus, Inc., Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, ezyVet Limited, NaVetor, Heska Corporation, Antech Diagnostics, Mars Science & Diagnostics, Ceva Sante Animale, Virbac S.A., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Animal Intelligence Software Inc. and SignalPET.

Key Developments:

In June 2026, Virbac S.A. launched an artificial intelligence-powered oncology treatment planning platform analyzing tumor characteristics and patient history to generate personalized chemotherapy and radiation protocols.

In May 2026, Elanco Animal Health Incorporated secured a major contract deploying care pathway management platforms across European veterinary specialty hospital networks for standardized chronic disease management protocols.

In April 2026, ezyVet Limited introduced a next-generation surgical planning solution integrating three-dimensional imaging with augmented reality visualization for precise orthopedic procedure planning in companion animals.

Solution Types Covered:

• Treatment Planning Software
• Clinical Decision Support Systems
• Care Pathway Management Platforms
• Prescription Management Solutions
• Therapy Planning Systems
• AI-Based Treatment Recommendation Platforms
• Integrated Clinical Workflow Solutions

Deployment Modes Covered:

• Cloud-Based
• On-Premises
• Hybrid Deployment
• Web-Based Platforms

Animal Types Covered:

• Companion Animals
• Livestock
• Equine
• Exotic Animals
• Aquatic Animals
• Wildlife

Treatment Types Covered:

• Medical Therapy
• Surgical Planning
• Rehabilitation Planning
• Oncology Treatment Planning
• Preventive Care Planning
• Chronic Disease Management

End Users Covered:

• Veterinary Hospitals
• Veterinary Clinics
• Diagnostic Laboratories
• Academic Institutions
• Research Organizations
• Telemedicine Providers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Veterinary Treatment Planning Market, By Solution Type

• 5.1 Treatment Planning Software
• 5.2 Clinical Decision Support Systems
• 5.3 Care Pathway Management Platforms
• 5.4 Prescription Management Solutions
• 5.5 Therapy Planning Systems
• 5.6 AI-Based Treatment Recommendation Platforms
• 5.7 Integrated Clinical Workflow Solutions

6 Global Veterinary Treatment Planning Market, By Deployment Mode

• 6.1 Cloud-Based
• 6.2 On-Premises
• 6.3 Hybrid Deployment
• 6.4 Web-Based Platforms

7 Global Veterinary Treatment Planning Market, By Animal Type

• 7.1 Companion Animals
• 7.2 Livestock
• 7.3 Equine
• 7.4 Exotic Animals
• 7.5 Aquatic Animals
• 7.6 Wildlife

8 Global Veterinary Treatment Planning Market, By Treatment Type

• 8.1 Medical Therapy
• 8.2 Surgical Planning
• 8.3 Rehabilitation Planning
• 8.4 Oncology Treatment Planning
• 8.5 Preventive Care Planning
• 8.6 Chronic Disease Management

9 Global Veterinary Treatment Planning Market, By End User

• 9.1 Veterinary Hospitals
• 9.2 Veterinary Clinics
• 9.3 Diagnostic Laboratories
• 9.4 Academic Institutions
• 9.5 Research Organizations
• 9.6 Telemedicine Providers

10 Global Veterinary Treatment Planning Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 IDEXX Laboratories, Inc
• 13.2 Covetrus, Inc.
• 13.3 Zoetis Inc.
• 13.4 Merck Animal Health
• 13.5 Boehringer Ingelheim Animal Health
• 13.6 ezyVet Limited
• 13.7 NaVetor
• 13.8 Heska Corporation
• 13.9 Antech Diagnostics
• 13.10 Mars Science & Diagnostics
• 13.11 Ceva Sante Animale
• 13.12 Virbac S.A.
• 13.13 Dechra Pharmaceuticals PLC
• 13.14 Elanco Animal Health Incorporated
• 13.15 Animal Intelligence Software Inc.
• 13.16 SignalPET